As of Oct 05
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 32.00, with a high estimate of 33.00 and a low estimate of 25.00. The median estimate represents a +148.45% increase from the last price of 12.88.
The current consensus among 6 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.